Clinical Features, Molecular Biology, and the Metastatic Microenvironment in Lung Cancer Brain Metastases: Implications for Treatment Decisions.

Adv Sci (Weinh) · 2025 · PMC12412593 · PMID 40719284

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

AK112 significantly improved PFS in the overall population (HR = 0.51, 95% CI 0.384–0.69) and showed a trend toward improved PFS in patients with BM (HR = 0.55, 95% CI 0.28–1.05) compared to pembrolizumab.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.